17 min ago | SBWire
NYSE Gainers Watch List: Verizon Communications Inc. (NYSE:VZ) and...
Growing Stock Report expands its NYSE Gainers Weekly Watch List adding Verizon Communications Inc. and Johnson & Johnson .
4 hrs ago | Illinoisreview
Thorner: Shortchanging of Secretary of HHS Scandal
All posts, comments and statements made on IR are those of the authors only. Any disputes must be addressed to the writers, who are solely responsible for their posts, comments and statements.
8 hrs ago | Fox News
Call for overhaul of drug industry business model
Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
12 hrs ago | The News-Press
The familiar red and green 7-Eleven sign is getting even more commonplace across Southwest Florida as the company targets the region for a major expansion effort.
It Might Be Time to Take Profits in Blue Chip Dividend Payers
James is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.
Ark. AG seeks to uphold verdict against J&J
Arkansas' attorney general filed a brief Tuesday backed by his counterparts in 35 other states asking the Arkansas Supreme Court to uphold a $1.2 billion fine levied against Johnson & Johnson and a subsidiary over the marketing of the antipsychotics drug Risperdal.
Ark. AG seeks to uphold verdict in drug case
Arkansas Attorney General Dustin McDaniel is asking the state's highest court to uphold a $1.2 billion fine leveled against Johnson and Johnson and a subsidiary over the marketing of an antipsychotic drug.
Eli Lilly & Co. (LLY), Alkermes Plc (ALKS): The FDA Might Pull This...
The Food and Drug Administration is investigating two deaths that occurred after patients were injected with Eli Lilly & Co.
Option Trends: Johnson & Johnson
Speculative players have been taking sides on blue chip Johnson & Johnson , automaker General Motors Company , and Finnish telecom concern Nokia Corporation , according to data from the major options exchanges.
Johnson & Johnson Gets Key Cancer Drug With Aragon Buy
Aside from concerns about the company's valuation, I didn't feel comfortable about Johnson & Johnson's margins; nor did I feel that the company's top-selling drug, Zytiga, was the answer to long-term prosperity.
Keep Up-to-Date with Current Health Sector Issues : Johnson & Johnson ...
Johnson & Johnson said Thursday it has decided to buy Aragon Medication Inc. for at least $650 thousand in money, enhancing its position in prostate medication growth.The independently owned San Paul organization is targeted on the growth of medication to cure hormonally motivated malignancies.
New Teardrop MemoryShape Silicone Gel Breast Implants Approved By...
With the approval of a new teardrop MemoryShape silicone breast implant, fears over the development of cancer from such implants have finally been addressed.
FDA approves new silicone breast implant from J&J
The Food and Drug Administration said Friday it approved a next-generation silicone breast implant from Johnson & Johnson unit Mentor.
UPDATE 2-J&J in $1 bln deal to bolster prostate-cancer focus
Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
Johnson & Johnson's Neutral Rating Reaffirmed at Sterne Agee
's stock had its "neutral" rating restated by equities researchers at Sterne Agee in a research report issued on Monday, StockRatingsNetwork.com reports.
J&J to Acquire Privately-Held Aragon Pharma
Johnson & Johnson agreed to buy privately-held drug developer Aragon Pharmaceuticals for as much as $1 billion on Monday as it looks to build-out its portfolio of drugs that treat hormonally-driven diseases like prostate cancer.
Staff Sterilization Scientist Job
Johnson & Johnson companies are equal opportunity employers. STAFF STERILIZATION SCIENTIST-0836130204 Description The Ethicon Surgical Care business a member of Johnson & Johnson&'s Family of Companies, is currently recruiting for a Staff Sterilization Scientist located in Albuquerque, NM.
UK scientists win funding for new kind of anticoagulant drug
British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously unachievable goal.
Johnson & Johnson's Depuy Synthes Wins $16 Million for Patents
Johnson & Johnson's DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc. when a jury decided that three of its patents were infringed.
Job Roundup for Sunday, June 16
The following job opportunities were listed as available in or near Oconee County last week.